Understanding Cannabis Inversion and New York's New Enforcement Framework
Background
Members of the Empire State Green Standard Alliance (ESGSA), including The West Firm's Mark Wagner, helped draw attention to issues of supply chain integrity and proposed policy solutions through ESGSA's Cannabis Inversion White Paper. Many of the concepts advanced in that white paper—including statutory definitions, enhanced traceability requirements, and stronger enforcement mechanisms—are reflected in the legislation that has now passed both houses of the Legislature.
New York's regulated cannabis market continues to evolve, with cannabis inversion emerging as a critical challenge to compliance, consumer safety, and licensed operators. This practice—where illicit or untested cannabis enters the legal supply chain—undermines market integrity, undercuts compliant businesses, and exposes consumers to potential risks. New York’s recently enacted Cannabis Supply Chain Integrity and Anti-Inversion Act represents a significant step forward, positioning the state as a potential national leader in addressing this issue.
Table of Contents
What Is Cannabis Inversion and Why Is It a Regulatory Concern?
Cannabis inversion refers to “any act or omission involving illicit cannabis”—typically meaning the introduction of unlicensed, out-of-state, or unregulated products into the legal marketplace through deceptive means, such as falsified records, manipulated testing, or broken chains of custody.
In a regulated system like New York’s, licensed cultivators, processors, distributors, and retailers must follow strict rules for testing, tracking, labeling, and taxation. Illicit products—often sourced from oversupplied states—bypass these requirements. They may be disguised as compliant New York-grown cannabis via falsified inventory reports, fraudulent certificates of analysis (COAs), or improper vendor relationships.
Key risks include:
Consumer safety: Illicit products often lack required testing for contaminants like pesticides, heavy metals, or molds, posing health risks. Other violations can result in products that either under or overreport the amount of THC they contain.
Market integrity: Licensed operators face unfair competition from cheaper, unregulated inventory that flood dispensaries.
Public health and trust: Widespread inversion erodes confidence in the legal market and can lead to higher diversion to the illicit market.
Regulatory challenges: Without robust traceability (such as a fully effective seed-to-sale system), enforcement becomes difficult.
The Empire State Green Standard Alliance (ESGSA) highlighted these concerns in its cannabis inversion white paper, which helped shape legislative action and raised awareness among policymakers and stakeholders.
New York-specific factors, such as the rapid rollout of adult-use dispensaries amid slower cultivation licensing and delays in full track-and-trace implementation, have amplified the issue.
Key Components of New York's Cannabis Inversion Legislation
New York has taken decisive action with the Cannabis Supply Chain Integrity and Anti-Inversion Act (S8951B/A10698B), which awaits Governor Hochul’s approval. Once enacted the Cannabis Supply Chain Integrity and Anti-Inversion Act into law, New York will be the first state to formally codify and penalize cannabis inversion.
Major provisions include:
Formal statutory definition: “Cannabis inversion” is defined as any act or omission involving illicit cannabis.
Direct prohibition: Bans activities that introduce or possess illicit cannabis in the regulated supply chain, including those with falsified or incomplete chain-of-custody documentation.
Prohibited practices: Explicitly targets falsified certificates of analysis, fraudulent testing results, manipulated inventory records, and other deceptive compliance tactics.
Expanded enforcement tools: Grants regulators (Office of Cannabis Management - OCM) broader investigative authority, license suspension powers (including temporary 30-day suspensions during probes), product seizure and destruction authority, and enhanced penalties.
Penalties: Civil fines of up to $10,000 per day, multipliers up to five times the revenue from prohibited activities, and additional sanctions for bad actors.
Recordkeeping and traceability: Reinforces chain-of-custody, inventory, testing, transfer, and tracking-record requirements, while establishing evidentiary standards for demonstrating lawful product origin.
Sponsored by key legislators including Senator Cooney and Assemblymember Landon Dais and others, the bill enjoyed broad bipartisan and industry support. It is expected to serve as a model for other states grappling with similar supply chain integrity issues.
Compliance Risks for Cannabis Businesses and When Legal Counsel May Be Necessary
Licensed cannabis businesses in New York face heightened scrutiny under the new framework. Even inadvertent involvement in the supply chain can trigger serious consequences.
Common compliance risks include:
Inventory control failures or discrepancies in tracking systems.
Recordkeeping deficiencies, such as missing or incomplete chain-of-custody documents.
Vendor verification concerns (e.g., sourcing from unverified suppliers).
Testing documentation issues or reliance on questionable COAs.
Regulatory investigations or audits by the OCM.
Product seizure exposure or license suspension/revocation risks.
Business interruption from enforcement actions.
Risk Overview Checklist:
Inventory control failures
Recordkeeping deficiencies
Vendor verification concerns
Testing documentation issues
Regulatory investigations
Product seizure exposure
License suspension risk
Timing Triggers for Legal Review:
New license applications or renewals
State investigations or notices of violation
Product recalls
Compliance audits
Supply chain disputes
Cannabis operators should maintain meticulous records demonstrating due diligence across their entire supply chain. If regulators identify discrepancies, prompt and strategic responses are essential to mitigate penalties and protect operations.
-
Yes. Licensees have due diligence obligations. Failure to verify suppliers or maintain proper documentation can result in liability, even without direct knowledge, depending on the facts and enforcement findings.
-
Businesses should keep comprehensive chain-of-custody documents, valid COAs from approved labs, inventory logs aligned with track-and-trace systems, vendor agreements, testing results, and records of all transfers. Consistency across systems is critical.
-
Immediately consult experienced legal counsel. Do not attempt to resolve independently. Preserve all records, cooperate transparently where advised, and work with attorneys familiar with OCM procedures to address findings and advocate for the business.
.png?content-type=image%2Fpng)